In our incident T2D cohort, higher Galectin-3, sST2, and GDF-15 tracked with greater EAT burden, inflammatory milieu, and early ventricular remodeling, consistent with biomarker elevation preceding overt dysfunction in metabolically at-risk individuals. Here, LGALS3 is linked to type 2 diabetes mellitus.